[144] ACM Research, Inc. SEC Filing
ACM Research, Inc. (ACMR) filed a Form 144 reporting a proposed sale of 70,000 common shares through Morgan Stanley Smith Barney LLC, scheduled approximately on 09/03/2025 on NASDAQ with an aggregate market value of $1,873,711.00. The filing shows these shares were acquired and paid for on 09/03/2025 by exercise of a stock option, with payment in cash to the issuer.
The notice states there were no other sales by the reporting person in the prior three months. The filer certifies they are unaware of any undisclosed material adverse information about the issuer. The document provides broker details and confirms the transaction source as an option exercise rather than a gift or third-party purchase.
- None.
- None.
Insights
TL;DR: A single insider-derived sale of 70,000 shares (~$1.87M) via Rule 144 appears routine and is disclosed per regulatory requirements.
The Form 144 indicates the shares were acquired by a same-day stock option exercise and are being offered for sale through Morgan Stanley Smith Barney on NASDAQ. Given the reported aggregate value relative to total outstanding shares (70,000 of 64,180,965), the transaction represents a small fraction of equity and is presented as a standard disposal under Rule 144. The filing includes the required certification about material non-public information and notes no prior sales in the three-month lookback period.
TL;DR: Compliance and disclosure norms are met; the filing documents an exercise-and-sell event rather than a transfer or gift.
From a governance perspective, the form provides the essential mechanics: date of acquisition and sale, nature of acquisition (stock option exercise), broker details, and a statement that no material nonpublic information is known. This meets Rule 144 disclosure expectations. The absence of other sales in the prior three months simplifies aggregation considerations. No governance irregularities are evident from the filing alone.